Jump to the Navigation Menu
Login to My AlzForum
Jump to the Search form

Papers

264419 Results

Sort By:

Publication Date
Journal Title
First Author
Most Commented

Go to another page:

17542
17543
17544
17545
17546
... 17628

Send results to Selected: 0 Clear selection

Sekiya M, Sakakibara Y, Hirota Y, Ito N, Chikamatsu S, Takei K, Nishijima R, Iijima KM. Decreased plasma nicotinamide and altered NAD+ metabolism in glial cells surrounding Aβ plaques in a mouse model of Alzheimer's disease. Neurobiol Dis. 2024 Oct 5;202:106694. PubMed.

Tirassa P, Rosso P, Fico E, Marenco M, Mallone F, Gharbiya M, Lambiase A, Severini C. Perspective role of Substance P in Amyotrophic Lateral Sclerosis: From neuronal vulnerability to neuroprotection. Neurosci Biobehav Rev. 2024 Oct 5;167:105914. PubMed.

Wen J, Yang Z, Nasrallah IM, Cui Y, Erus G, Srinivasan D, Abdulkadir A, Mamourian E, Hwang G, Singh A, Bergman M, Bao J, Varol E, Zhou Z, Boquet-Pujadas A, Chen J, Toga AW, Saykin AJ, Hohman TJ, Thompson PM, Villeneuve S, Gollub R, Sotiras A, Wittfeld K, Grabe HJ, Tosun D, Bilgel M, An Y, Marcus DS, LaMontagne P, Benzinger TL, Heckbert SR, Austin TR, Launer LJ, Espeland M, Masters CL, Maruff P, Fripp J, Johnson SC, Morris JC, Albert MS, Bryan RN, Resnick SM, Ferrucci L, Fan Y, Habes M, Wolk D, Shen L, Shou H, Davatzikos C. Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer's disease continuum. Transl Psychiatry. 2024 Oct 5;14(1):420. PubMed.

Cubas Guillen JF, Chrem Méndez P, Surace E, Martin ME, Clarens F, Russo J, Harris P, Egido N, Tapajoz F, Chaves H, Vázquez S, Martinetto H, Campos J, Calandri IL, Sevlever G, Allegri RF. Argentina-Alzheimer's Disease Neuroimaging Initiative: pioneering Alzheimer's Research in Latin America and its Implications for Regional Advancement. Alzheimers Dement. 2024 Oct 6; PubMed.

Custodio N, Allegri R, Lopera F, Caramelli P. Need to adapt Alzheimer's disease criteria in Latin America. Alzheimers Dement. 2024 Oct 6; PubMed.

Eratne D, Kang MJ, Lewis C, Dang C, Malpas CB, Keem M, Grewal J, Marinov V, Coe A, Kaylor-Hughes C, Borchard T, Keng-Hong C, Waxmann A, Saglam B, Kalincik T, Kanaan R, Kelso W, Evans A, Farrand S, Loi S, Walterfang M, Stehmann C, Li QX, Collins S, Masters CL, Santillo AF, Zetterberg H, Blennow K, Berkovic SF, Velakoulis D, MiND Study Group. Plasma and CSF neurofilament light chain distinguish neurodegenerative from primary psychiatric conditions in a clinical setting. Alzheimers Dement. 2024 Oct 6; PubMed.

Mielke MM, Anderson M, Ashford JW, Jeromin A, Lin PJ, Rosen A, Tyrone J, VandeVrede L, Willis D, Hansson O, Khachaturian AS, Schindler SE, Weiss J, Batrla R, Bozeat S, Dwyer JR, Holzapfel D, Jones DR, Murray JF, Partrick KA, Scholler E, Vradenburg G, Young D, Braunstein JB, Burnham SC, de Oliveira FF, Hu YH, Mattke S, Merali Z, Monane M, Sabbagh MN, Shobin E, Weiner MW, Udeh-Momoh CT. Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease. Alzheimers Dement. 2024 Oct 6; PubMed.

Nakamura Y, Adachi J, Hirota N, Iba K, Shimizu K, Nakai M, Takahashi K, Mori N. Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study. Alzheimers Dement. 2024 Oct 6; PubMed.

Potter WZ, Buckholtz NS, Paul SM. The origins of ADNI. Alzheimers Dement. 2024 Oct 6; PubMed.

Sandoval C, Lee J, Toth B, Nagaraj R, Schauer SP, Hoffman J, Calderon E, Kollmorgen G, Sanabria Bohórquez SM, Monteiro C, Teng E, Hanson JE, Yeh FL, Gutierrez J, Biever A. CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti-tau antibody semorinemab. Alzheimers Dement. 2024 Oct 6; PubMed.

Satyanarayanan SK, Han Z, Xiao J, Yuan Q, Yung WH, Ke Y, Chang RC, Zhu MH, Su H, Su KP, Qin D, Lee SM. Frontiers of Neurodegenerative Disease Treatment: Targeting Immune Cells in Brain Border Regions. Brain Behav Immun. 2024 Oct 6;123:483-499. PubMed.

Brinza I, Boiangiu RS, Mihasan M, Gorgan DL, Stache AB, Abd-Alkhalek A, El-Nashar H, Ayoub I, Mostafa N, Eldahshan O, Singab AN, Hritcu L. Rhoifolin, baicalein 5,6-dimethyl ether and agathisflavone prevent amnesia induced in scopolamine zebrafish (Danio rerio) model by increasing the mRNA expression of bdnf, npy, egr-1, nfr2α, and creb1 genes. Eur J Pharmacol. 2024 Oct 6;984:177013. PubMed.

Theeke LA, Liu Y, Wang S, Luo X, Navia RO, Xiao D, Xu C, Wang K, The Alzheimer And Disease Neuroimaging Initiative. Plasma Proteomic Biomarkers in Alzheimer's Disease and Cardiovascular Disease: A Longitudinal Study. Int J Mol Sci. 2024 Oct 6;25(19) PubMed.

Li Y, Zhang J, Ma B, Yu W, Xu M, Luan W, Yu Q, Zhang L, Rong R, Fu Y, Cao H. Nanotechnology used for siRNA delivery for the treatment of neurodegenerative diseases: Focusing on Alzheimer's disease and Parkinson's disease. Int J Pharm. 2024 Oct 6;666:124786. PubMed.

Otani N, Kanda K, Ngatu NR, Murakami A, Yamadori Y, Hirao T. Association between Polypharmacy and Adverse Events in Patients with Alzheimer's Disease: An Analysis of the Japanese Adverse Drug Event Report Database (JADER). Medicina (Kaunas). 2024 Oct 6;60(10) PubMed.

Go to another page:

17542
17543
17544
17545
17546
... 17628

Current Filters

No filters selected

Filter By

Papers of the Week

Current Week (103)
1-7 Nov 2024 (92)
25-31 Oct 2024 (195)
18-24 Oct 2024 (285)

Type ?

Milestone (286)
Alzforum Recommends (3828)

Publication Range

From
1. Month
2. Year
To
1. Month
2. Year

Background
Methods
FAQ

Enter your keywords

LOGIN
HOME
About Us
Newsletter

NEWS
- All News
- Conference Coverage
WEBINARS
- All Webinars
Databases
- AlzAntibodies
- AlzBiomarker
- AlzPedia
- AlzRisk
- Brain Banks
- Genetics
  - AlzGene
  - HEX
  - Mutations
- Protocols
- Research Models
- Therapeutics
PAPERS
PROFESSIONAL RESOURCES
ABOUT AD
MY ALZFORUM

Back to the Top

Terms of Service
How to Cite
Privacy Policy
Site Map
Contact Us